📊 Full opportunity report: The Forecast Is the Plan. on ThorstenMeyerAI.com — validation score, market gap, and execution plan.
TL;DR
Leading AI companies publicly plan to automate core R&D tasks by September 2026, signaling a strategic industry shift. This move indicates automation is now a concrete goal, not just an aspiration.
Major AI labs, including OpenAI, Anthropic, and DeepMind, have publicly committed to automating key AI research functions by September 2026, marking a significant shift in industry strategy. These commitments are not vague goals but specific, calendar-driven plans that signal automation as an explicit objective, with potential impacts on the AI workforce and research processes.
OpenAI’s CEO Sam Altman announced in October 2025 that the company aims to develop an automated AI research intern by September 2026, capable of performing entry-level research tasks such as reading, summarizing, and implementing experiments. This specific target indicates a strategic move toward automating the foundational roles in AI development.
Anthropic has publicly detailed its ‘Automated Alignment Researchers’ program, which aims to build AI systems capable of conducting AI alignment research autonomously. The program’s operational results, including AI agents outperforming human baselines, demonstrate progress toward automating complex safety research tasks.
DeepMind’s approach remains more cautious, with its published paper stating that automation of alignment research ‘should be done when feasible,’ implying a readiness to pursue automation once technological capabilities allow. This cautious framing contrasts with the more explicit commitments of OpenAI and Anthropic.
Additionally, Recursive Superintelligence has raised $500 million for a dedicated lab focused on automating AI R&D, reflecting significant investor confidence in the feasibility and timeline of automation breakthroughs. Mirendil, a newer entrant, aims to build systems that excel at AI R&D, further emphasizing industry-wide strategic shifts toward automation.
The forecast
is the plan.
Five labs. Hundreds of billions of capital. Calendar targets within 32 months. The labs are building what they say they’re building.
Jack Clark’s closing section catalogs the explicit, public, on-the-record corporate commitments to automating AI R&D. OpenAI: “automated AI research intern by September 2026.” Anthropic: Automated Alignment Researchers. DeepMind: “automation of alignment research should be done when feasible.” Plus neolabs Recursive Superintelligence ($500M) and Mirendil. The headline finding: Clark’s 60%/2028 forecast is structurally a corporate plan, not a probability estimate.
Five labs. One stated goal.
Clark catalogs five distinct public commitments to automating AI R&D. Each individually is significant; the pattern across them is more so. When the industry uniformly commits and capital flows to support, the probability of execution rises substantially — not by magic but because thousands of researchers and engineers are deliberately working to produce the outcome.
TARGET
PROGRAM
FEASIBLE”
SERIES A
STATEMENT
The No-BS Guide to AI for Trading & Market Research: How to Use ChatGPT, Claude & AI Tools for Market Analysis, Stock Research & Data-Driven Trading … … Required (The No-BS AI Playbooks Book 3)
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Hundreds of billions. Itemized.
Clark mentions “hundreds of billions” without itemizing. The verifiable scale from public sources. When capital concentrates around five-to-seven specific organizations with a stated objective, those organizations become the structural lever for whether the objective is achieved.
AI accelerates cognitive work. It does not accelerate everything.
Clark introduces a structural observation worth developing. Amdahl’s Law from computer architecture, applied to the economy. As AI accelerates the cognitive-work layer, queues form at non-cognitive layers. The economic disruption from AI is concentrated rather than distributed.
- Software engineering
- Financial analysis
- Marketing & copy
- Legal research
- Customer service
- Code review & documentation
30-50%+ productivity gains
- Drug trials (clinical trials, FDA)
- Infrastructure construction
- Legislative cycles
- Biological/chemical processes
- Trust-building & B2B sales
- Regulated industries broadly
Queues at the slow part
Who gets the AI productivity multiplier?
Clark: “demand for AI continues to outstrip compute supply” and “market incentives don’t guarantee best societal upside from limited AI compute.” The compute allocation question is who captures the multiplier.
“Figuring out how to allocate the acceleratory capabilities conferred by AI R&D will be a politically charged problem.“
Five dimensions Clark gestures at but leaves underdeveloped.
Clark’s closing section is rigorous on the corporate commitment evidence. Five strategic dimensions matter for the institutional response that the synthesis-level read argues is structurally inadequate.
FAILURE
CONSEQUENCES
RACE
INFRA GAP
Use corporate commitments as the input.
The corporate commitments are more concrete than the published forecasts. Plan to calendar markers, not to probability distributions.
POLICYMAKERS
INVESTORS
COGNITIVE WORKERS
RESEARCHERS
EVERYONE ELSE
The labs are building what they say they’re building. The forecast is the plan. The institutional response window is the only variable that remains unfixed.
Implications of Industry-Wide Automation Commitments
This pattern of public commitments indicates that automating AI research is now an explicit industry goal, not merely an aspirational or emergent property. If these targets are met, a substantial portion of the AI research workforce could become automatable within the next year, fundamentally transforming how AI is developed and deployed. The commitments also suggest that automation is viewed as a strategic advantage, with implications for safety, efficiency, and competitive positioning.
Moreover, these plans could accelerate the pace of AI capability development, potentially leading to rapid advances in AI systems and raising questions about safety, oversight, and governance. The industry’s transparency about these goals signals a shift toward more strategic, goal-oriented R&D efforts.
Industry Commitments Signal a Strategic Shift in AI R&D
Over the past year, leading AI organizations have increasingly articulated explicit goals to automate core research tasks. OpenAI’s September 2026 target for an automated research intern was announced publicly in late 2025, serving as a clear milestone for automation efforts. Anthropic’s research program, published earlier this year, demonstrates operational progress in automating alignment research, a critical safety domain.
DeepMind’s more cautious framing reflects an awareness of the technical challenges, but the language indicates a willingness to pursue automation once feasible. The significant capital raised by Recursive Superintelligence and the emergence of neolabs like Mirendil further underscore the industry’s collective move toward automating R&D as a strategic priority.
These commitments are part of a broader pattern where automation is not an incidental goal but an explicit, publicly stated objective, signaling a fundamental shift in how AI research is planned and executed.
“Our Automated Alignment Researchers program demonstrates progress in building AI that can conduct safety research autonomously.”
— Dario Amodei, CEO of Anthropic
Technical and Strategic Challenges to Automation
It remains unclear whether these public commitments will be fully realized by the target dates, as technical challenges in automating complex research tasks persist. The pace of progress in AI capabilities and safety measures will influence whether these plans are achieved on schedule. Additionally, the broader industry response and regulatory environment could impact the feasibility of rapid automation deployment.
While progress is demonstrated in some operational results, the transition from current capabilities to fully autonomous research systems involves uncertainties around reliability, safety, and oversight, which are still being addressed.
Next Milestones and Industry Response
Over the coming months, the industry will likely evaluate progress toward OpenAI’s September 2026 target, with updates on prototype capabilities and safety assessments. Continued publication of operational results from Anthropic and other labs will clarify how close the industry is to fully automating core R&D functions.
Further investor funding, regulatory discussions, and collaborative efforts will shape how these commitments translate into actual deployed systems. Monitoring these developments will be key to understanding the pace and impact of this strategic shift in AI research.
Key Questions
What does automating AI research tasks mean in practice?
It involves developing AI systems capable of performing foundational research activities such as reading scientific papers, summarizing findings, implementing experiments, and even conducting safety research autonomously.
Why are these commitments significant for the AI industry?
They signal a strategic shift where automation is a core goal, potentially accelerating AI development, reducing research costs, and transforming workforce roles involved in AI R&D.
What are the main technical challenges remaining?
Achieving reliable, safe, and generalizable autonomous research systems remains difficult. Capabilities must improve in reasoning, safety, and oversight to fully automate complex tasks.
Could regulatory or safety concerns delay these plans?
Yes, safety, oversight, and regulatory issues could influence the timeline and scope of automation deployment, especially as systems become more autonomous and capable.
What happens if these automation targets are missed?
Missing the targets could slow industry momentum, impact investor confidence, and prompt reassessment of automation strategies. However, the commitments reflect strategic intent, not guaranteed outcomes.
Source: ThorstenMeyerAI.com
